Stryker Corporation $SYK Shares Acquired by Talbot Financial LLC

Talbot Financial LLC increased its holdings in Stryker Corporation (NYSE:SYK) by 22.7% in the third quarter, HoldingsChannel reports. The firm owned 71,125 shares of the medical technology company’s stock after purchasing an additional 13,179 shares during the period. Stryker accounts for approximately 1.4% of Talbot Financial LLC’s portfolio, making the stock its 24th biggest holding. Talbot Financial LLC’s holdings in Stryker were worth $19,587,000 at the end of the most recent quarter.

Several other hedge funds have also recently bought and sold shares of SYK. Bank of America Corp DE bought a new position in Stryker during the second quarter valued at about $1,404,284,000. Legal & General Group Plc bought a new stake in shares of Stryker during the 2nd quarter worth about $707,212,000. Jupiter Topco LLC bought a new stake in shares of Stryker during the 2nd quarter worth about $681,581,000. Corient Private Wealth LP acquired a new position in shares of Stryker during the 2nd quarter valued at about $323,035,000. Finally, Flossbach Von Storch SE acquired a new position in shares of Stryker during the 2nd quarter valued at about $464,506,000. 77.09% of the stock is owned by institutional investors and hedge funds.

Stryker Stock Performance

Shares of Stryker stock traded up $4.48 during trading on Monday, reaching $299.14. The company’s stock had a trading volume of 1,390,818 shares, compared to its average volume of 2,444,056. The company has a debt-to-equity ratio of 0.59, a quick ratio of 1.33 and a current ratio of 2.16. The business’s fifty day moving average price is $299.31 and its 200-day moving average price is $312.76. The firm has a market cap of $114.74 billion, a price-to-earnings ratio of 31.00, a price-to-earnings-growth ratio of 1.87 and a beta of 0.78. Stryker Corporation has a one year low of $267.00 and a one year high of $392.55.

Stryker (NYSE:SYK) last posted its quarterly earnings data on Thursday, July 30th. The medical technology company reported $3.69 earnings per share for the quarter, topping the consensus estimate of $3.49 by $0.20. Stryker had a return on equity of 23.63% and a net margin of 14.43%. The business had revenue of $6.59 billion during the quarter, compared to analysts’ expectations of $6.58 billion. During the same quarter in the previous year, the firm earned $3.13 EPS. The firm’s revenue was up 9.4% compared to the same quarter last year. Stryker has set its FY 2026 guidance at 14.950-15.100 EPS. As a group, equities research analysts predict that Stryker Corporation will post 14.93 earnings per share for the current year.

Stryker Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th will be issued a dividend of $0.88 per share. The ex-dividend date is Wednesday, September 30th. This represents a $3.52 dividend on an annualized basis and a dividend yield of 1.2%. Stryker’s payout ratio is 36.48%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on SYK. Stifel Nicolaus cut their price objective on Stryker from $360.00 to $330.00 and set a “buy” rating on the stock in a research note on Wednesday, September 30th. Barclays raised Stryker to a “strong-buy” rating in a research report on Wednesday, October 7th. Citigroup lowered their price target on Stryker from $399.00 to $360.00 and set a “buy” rating on the stock in a report on Thursday, September 10th. Weiss Ratings reissued a “hold (c)” rating on shares of Stryker in a research report on Friday, July 31st. Finally, Piper Sandler reduced their price objective on shares of Stryker from $420.00 to $390.00 and set an “overweight” rating for the company in a research note on Friday, July 31st. One research analyst has rated the stock with a Strong Buy rating, seventeen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $369.00.

Insider Transactions at Stryker

In other news, Director Ronda Stryker sold 300,000 shares of the stock in a transaction that occurred on Tuesday, August 18th. The stock was sold at an average price of $335.90, for a total value of $100,770,000.00. Following the completion of the sale, the director directly owned 2,301,375 shares of the company’s stock, valued at approximately $773,031,862.50. This represents a 11.53% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Dylan Crotty sold 441 shares of the stock in a transaction that occurred on Friday, August 21st. The shares were sold at an average price of $328.61, for a total value of $144,917.01. Following the completion of the sale, the insider directly owned 6,102 shares of the company’s stock, valued at $2,005,178.22. This represents a 6.74% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders sold a total of 351,267 shares of company stock worth $118,197,701 over the last three months. 4.60% of the stock is currently owned by insiders.

About Stryker

Stryker Corporation (NYSE: SYK) is a global medical technology company that develops and manufactures products used by healthcare providers in hospitals, surgical centers and other clinical settings. Its offerings are designed to support orthopaedic procedures, surgery, emergency care, neurovascular treatment and patient handling.

The company’s product portfolio includes orthopaedic implants and instruments, products for trauma and spine procedures, surgical equipment, endoscopy systems, patient beds and stretchers, emergency medical equipment, and neurovascular devices used in the treatment of conditions such as stroke.